Literature DB >> 25309085

Study of liver cirrhosis over ten consecutive years in Southern China.

Xing Wang1, Shang-Xiong Lin1, Jin Tao1, Xiu-Qing Wei1, Yuan-Ting Liu1, Yu-Ming Chen1, Bin Wu1.   

Abstract

AIM: To investigate the etiology and complications of liver cirrhosis (LC) in Southern China.
METHODS: In this retrospective, cross-sectional study, we identified cases of liver cirrhosis admitted between January 2001 to December 2010 and reviewed the medical records. Patient demographics, etiologies and complications were collected, and etiological changes were illustrated by consecutive years and within two time periods (2001-2005 and 2006-2010). All results were expressed as the mean ± SD or as a percentage. The χ(2) test or Student's t-test was used to analyze the differences in age, gender, and etiological distribution, and one-way analysis of variance was applied to estimate the trends in etiological changes. We analyzed the relationship between the etiologies and complications using unconditioned logistic regression, and the risk of upper gastrointestinal bleeding (UGIB) and hepatocellular carcinoma (HCC) in the major etiological groups was evaluated as ORs. A P value less than 0.05 was considered significant. Statistical computation was performed using SPSS 17.0 software.
RESULTS: In this study, we identified 6719 (83.16%) male patients and 1361 (16.84%) female patients. The average age of all of the patients was 50.5 years at the time of diagnosis. The distribution of etiological agents was as follows: viral hepatitis, 80.62% [hepatitis B virus (HBV) 77.22%, hepatitis C virus (HCV) 2.80%, (HBV + HCV) 0.58%]; alcohol, 5.68%; mixed etiology, 4.95%; cryptogenic, 2.93%; and autoimmune hepatitis, 2.03%; whereas the other included etiologies accounted for less than 4% of the total. Infantile hepatitis syndrome LC patients were the youngest (2.5 years of age), followed by the metabolic LC group (27.2 years of age). Viral hepatitis, alcohol, and mixed etiology were more prevalent in the male group, whereas autoimmune diseases, cryptogenic cirrhosis, and metabolic diseases were more prevalent in the female group. When comparing the etiological distribution in 2001-2005 with that in 2006-2010, the proportion of viral hepatitis decreased from 84.7% to 78.3% (P < 0.001), and the proportion of HBV-induced LC also decreased from 81.9% to 74.6% (P < 0.001). The incidence of mixed etiology, cryptogenic cirrhosis, and autoimmune diseases increased by 3.1% (P < 0.001), 0.5% (P = 0.158), and 1.3% (P < 0.001), respectively. Alcohol-induced LC remained relatively steady over the 10-year period. The ORs of the development of UGIB between HBV and other major etiologies were as follows: HCV, 1.07; alcohol, 1.89; autoimmune, 0.90; mixed etiology, 0.83; and cryptogenic, 1.76. The ORs of the occurrence of HCC between HBV and other major etiologies were as follows: HCV, 0.54; alcohol, 0.16; autoimmune, 0.05; mixed etiology, 0.58; and cryptogenic, 0.60.
CONCLUSION: The major etiology of liver cirrhosis in Southern China is viral hepatitis. However, the proportions of viral hepatitis and HBV are gradually decreasing. Alcoholic LC patients exhibit a greater risk of experiencing UGIB, and HBV LC patients may have a greater risk of HCC.

Entities:  

Keywords:  Complication; Epidemiology; Etiology; Hepatocellular carcinoma; Liver cirrhosis; Southern China

Mesh:

Year:  2014        PMID: 25309085      PMCID: PMC4188906          DOI: 10.3748/wjg.v20.i37.13546

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  43 in total

Review 1.  Viral pathogenesis of hepatocellular carcinoma.

Authors:  Hubert E Blum; Darius Moradpour
Journal:  J Gastroenterol Hepatol       Date:  2002-12       Impact factor: 4.029

2.  The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease.

Authors:  Stephen H Caldwell; Deborah M Crespo
Journal:  J Hepatol       Date:  2004-04       Impact factor: 25.083

3.  Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.

Authors:  Guadalupe Garcia-Tsao; Arun J Sanyal; Norman D Grace; William Carey
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

4.  Vascular disorders of the liver.

Authors:  Laurie D DeLeve; Dominique-Charles Valla; Guadalupe Garcia-Tsao
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

5.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

Review 6.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

7.  Etiology of liver cirrhosis in Japan: a nationwide survey.

Authors:  Kojiro Michitaka; Shuhei Nishiguchi; Yutaka Aoyagi; Yoichi Hiasa; Yoshio Tokumoto; Morikazu Onji
Journal:  J Gastroenterol       Date:  2009-09-30       Impact factor: 7.527

Review 8.  Neonatal hepatitis syndrome.

Authors:  Eve A Roberts
Journal:  Semin Neonatol       Date:  2003-10

9.  Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study.

Authors:  Mårten Werner; Hanne Prytz; Bodil Ohlsson; Sven Almer; Einar Björnsson; Annika Bergquist; Sven Wallerstedt; Hanna Sandberg-Gertzén; Rolf Hultcrantz; Per Sangfelt; Ola Weiland; Ake Danielsson
Journal:  Scand J Gastroenterol       Date:  2008       Impact factor: 2.423

10.  Etiologies of chronic liver diseases in Hong Kong.

Authors:  Konrad Tang-Tat Fung; James Fung; Ching-Lung Lai; Man-Fung Yuen
Journal:  Eur J Gastroenterol Hepatol       Date:  2007-08       Impact factor: 2.566

View more
  20 in total

1.  Studied microRNA gene expression in human hepatocellular carcinoma by microRNA microarray techniques.

Authors:  Jian-Xiang Niu; Xing-Kai Meng; Jian-Jun Ren
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

2.  Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study.

Authors:  Dan-Hong Yang; Wei-Ping Wang; Qiang Zhang; Hong-Ying Pan; Yi-Cheng Huang; Jia-Jie Zhang
Journal:  World J Gastroenterol       Date:  2021-05-07       Impact factor: 5.742

3.  Association between lymphocyte-to-monocyte ratio (LMR) and the mortality of HBV-related liver cirrhosis: a retrospective cohort study.

Authors:  Jie Zhang; Guofang Feng; Ying Zhao; Juanwen Zhang; Limin Feng; Jing Yang
Journal:  BMJ Open       Date:  2015-08-21       Impact factor: 2.692

4.  miR-199a-3p inhibits cell proliferation and induces apoptosis by targeting YAP1, suppressing Jagged1-Notch signaling in human hepatocellular carcinoma.

Authors:  Kewei Ren; Tengfei Li; Wenzhe Zhang; Jianzhuang Ren; Zhen Li; Gang Wu
Journal:  J Biomed Sci       Date:  2016-11-10       Impact factor: 8.410

5.  Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis B.

Authors:  Hong You; Yuanyuan Kong; Jinlin Hou; Lai Wei; Yuexin Zhang; Junqi Niu; Tao Han; Xiaojuan Ou; Xiaoguang Dou; Jia Shang; Hong Tang; Qing Xie; Huiguo Ding; Hong Ren; Xiaoyuan Xu; Wen Xie; Xiaoqing Liu; Youqing Xu; Yujie Li; Jie Li; Shein-Chung Chow; Hui Zhuang; Jidong Jia
Journal:  Sci Rep       Date:  2016-11-28       Impact factor: 4.379

6.  Liver cirrhosis caused by chronic Budd-Chiari syndrome.

Authors:  Mengjie Lin; Feng Zhang; Yi Wang; Bin Zhang; Wei Zhang; Xiaoping Zou; Ming Zhang; Yuzheng Zhuge
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

Review 7.  Cryptococcal pleuritis with pleural effusion as the only clinical presentation in a patient with hepatic cirrhosis: A case report and literature review.

Authors:  Jie Wang; Jin-Jing Hong; Piao-Piao Zhang; Mei-Fang Yang; Qing Yang; Ting-Ting Qu
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

8.  Clinical Predictors Impacting Cryptococcal Dissemination and Poor Outcome in Patients With Cirrhosis.

Authors:  Jia-Hui Cheng; Ching-Wan Yip; Ying-Kui Jiang; Ling-Hong Zhou; Chun-Xing Que; Yu Luo; Xuan Wang; Hua-Zhen Zhao; Li-Ping Zhu
Journal:  Open Forum Infect Dis       Date:  2021-06-05       Impact factor: 3.835

Review 9.  Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects.

Authors:  Ming Hong; Sha Li; Hor Yue Tan; Ning Wang; Sai-Wah Tsao; Yibin Feng
Journal:  Int J Mol Sci       Date:  2015-12-02       Impact factor: 5.923

10.  Changing the cause of liver cirrhosis from hepatitis B virus to fatty liver in Iranian patients.

Authors:  Behzad Hatami; Sara Ashtari; Afsaneh Sharifian; Hamideh Rahmani Seraji; Elmira Khalili; Yasin Hatami; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.